INS and pancreatic insulinoma: In the NIH series of studies on insulinoma, the researchers proposed to increase the insulin and proinsulin thresholds to 5 μIU/ml and 22 pmol/L, respectively, leading to higher specificity of 98% and 100% but lowering the sensitivity for insulin to 91%, regardless of the blood glucose level (13).